PK/PD Modeling Exercise with Dr. Cody J. Peer Published 2019-10-31 Download video MP4 360p Download video MP4 720p Recommendations 11:46 Discussion on Clinical Trial Endpoints with Dr. Barry Goldspiel 58:50 Animal Scale Up and First-in-Human Studies with Dr. Jerry Collins 19:03 Introduction to Module 6 with Dr. William Zamboni 36:37 Essentials of Antibiotic Dosing: Pharmacokinetics and Pharmacodynamics 1:20:11 Drug Formulation & Delivery with Dr. Robert Ternik 39:48 Dr Joseph Standing: Understanding and applying PKPD concepts in your clinical practice 1:22:27 Introduction to Clinical Pharmacology and Therapeutics with Dr. Juan J.L. Lertora 03:18 The benefits of using Pharmacokinetic and Pharmacodynamic modeling 1:22:09 Population Pharmacokinetics with Dr. Robert R. Bies 56:13 MDC Connects: Understanding the PK / PD Relationship 48:44 Drug Transport Across the Blood Brain Barrier with Dr. Sadhana Jackson 36:36 Introduction to Pharmacology, Drug Development and Clinical Pharmacology with Dr. William D. Figg 28:38 Introduction to Clinical Pharmacology and Therapeutics - Part 1: Overview of Clinical Pharmacology 54:05 Using PK Data for Better In Vitro and In Vivo Drug Dosing and Study Design 44:18 Jim Wells and Michelle Arkin(UCSF) Part 1: Introduction to Drug Discovery 52:51 Pharmacodynamic and Pharmacokinetic Modeling of Data with Dr. Joga Gobburu 1:44:58 Why Sleep Matters 49:40 PBPK modeling and simulation: Bridging the “Bottom Up” and “Top-Down” Approaches 05:35 Pharmacokinetics 3 - Distribution 54:09 Introduction to Clinical Pharmacology and Therapeutics - Part 2: Pharmacokinetic Concepts Similar videos 55:39 A Best Practice Framework for Applying PBPK Modeling to Pediatric Drug Development 1:29:56 Pharmacokinetics/Pharmacodynamics of Protein Drugs with Dr. Jürgen Venitz 32:24 Drug Development Process - TOX, ADME, PK/PD, Clinical POC and Drug Approval 1:00:37 Lab 7 - MI210: Essentials of Population PK-PD Modeling and Simulation (2010) 22:23 Application of PBPK Modelling to Drug Development Decisions | Joga Gobburu, PhD, MBA 1:03:46 PK/PD for β-lactamase Inhibitor Combinations in Drug Development for Resistant Bacteria 46:53 Using a PK/PD model for simulation-based assessment of probability of technical success in drug d... 09:20 Application of PKPD Model 1:59:56 Lecture 7 - MI210: Essentials of Population PK-PD Modeling and Simulation (2010) 18:14 Using Pop PK Modeling to Optimize Dosing in Patients with Organ Impairment 59:39 Physiologically Based Pharmacokinetic Modelling for First‑In‑Human Predictions 58:18 Precision HIV PrEP – Tailoring the Prescription for the User 11:01 PK/PD of Protein Drugs: A Case Study with Dr. Jürgen Venitz 30:46 Physiologically based pharmacokinetic modeling for the simulation of relevant clinical scenarios 2:03:11 Day 3: PK-PD Relationships and Safety Pharmacology More results